Evaxion Biotech (EVAX) Tops Q1 EPS by 8c

Evaxion Biotech (NASDAQ: EVAX) reported Q1 EPS of ($0.25), $0.08 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Evaxion presents preclinical data for acute myeloid leukemia vaccine
• UBS Reiterates Neutral Rating on Clorox (CLX) as External Challenges Persist